This Government Contract opportunity from Department Of Veterans Affairs was posted on June 10, 2025. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

6505--770_Pharmaceuticals_VA CMOP National Office_36C77025Q0206

Awarded

36C77025Q0206Federal

Submission Closed06/10/2025, 12:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412

New

International

Pralidoxime Chloride/Methyl Sulfate ManufacturingThis subcontract involves the manufacture and supply of Pralidoxime chloride or methyl sulfate in solution or powder form for injection to support prime contractors on Department of National Defence projects. The required product must have a dosage strength of at least 200 mg per container and a minimum shelf-life of 36 months. The selected provider is responsible for conducting stability testing, providing quality assurance certification, and delivering complete treatment courses along with stability reports and product monographs. To be eligible, the manufacturer must hold a Health Canada Notice of Compliance under Division 8 or Division 11 authorization. This global procurement opportunity is managed by the Government of Canada and allows for performance across various international regions. Interested parties must submit their responses by November 10, 2026.

Department of National Defence

POSTED

DEADLINE

SLS Printer Consumables and Maintenance KitsThis subcontract focuses on the provision of specialized consumables and wear-and-tear replacement parts to support prime contractors working on Department of National Defence projects for the Government of Canada. The scope of supply includes engineering-grade thermoplastic powders such as PA 11, PA 12, PP, and TPU, along with critical SLS hardware components including optical cassettes, recoater blades, infrared heaters, sealing foam gaskets, and build chambers. All bulk consumables and spare parts kits are to be delivered to CFB Petawawa. The opportunity was posted on October 20, 2026, with a response deadline of November 2, 2026, falling under NAICS code 325412.

Department of National Defence

POSTED

DEADLINE

Supplier of Red Sealing Compound (NSN 8030015650423)This subcontract involves the supply of red sealing compound, identified by NSN 8030015650423, for prime contractors working under the Defense Logistics Agency. The material must be provided in 10.00 milliliter containers and strictly adhere to the DLA Master List of Technical and Quality Requirements RA001. The supplier is responsible for managing TYPE I (CODE H) shelf-life requirements and ensuring all packaging complies with MIL-STD-2073-1E and MIL-STD-129 standards. Additionally, the contractor must provide all necessary safety documentation, including SDS and HazCom labels in accordance with 29 C.F.R. 1910.1200. The performance of this contract is centered in FPO 09591-0100, with the primary objective being the delivery of packaged sealing compound and its associated safety certifications to the Department of Defense.

Defense Logistics Agency

POSTED

DEADLINE

Active Pharmaceutical Ingredient (API) SupplyThis subcontract for Active Pharmaceutical Ingredient (API) Supply involves the synthesis, purification, and bulk delivery of pharmaceutical-grade Benzocaine and Menthol. The provider supports prime contractors fulfilling requirements for the Department of Defense Medical Supply Chain Pharm FSA, ensuring all raw chemical components meet strict USP and ISO manufacturing standards through the use of HPLC purity testing. The performance of this contract is centered at Fort Campbell, Kentucky, under NAICS code 325412. The solicitation was posted on October 19, 2026, with a response deadline of October 26, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Benzocaine and Menthol Lozenge SupplyThis subcontract involves the manufacture and supply of finished Benzocaine and Menthol lozenges to prime contractors supporting the Department of Defense Medical Supply Chain Pharm FSA. The provider is responsible for producing and quality-testing pharmaceutical lozenges within FDA-compliant facilities adhering to Good Manufacturing Practice standards to ensure all delivered quantities meet strict government specifications. Administrative processes for this requirement are managed through the DLA Internet Bid Board System for quote submissions. The performance of the contract is centered at Fort Campbell, and the procurement falls under NAICS code 325412 for pharmaceutical preparation.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Moxifloxacin Hydrochloride Tablets (400 MG)This subcontract, managed by the Medical Supply Chain Pharm FSA under the Department of Defense, involves the manufacture and supply of pharmaceutical-grade Moxifloxacin Hydrochloride Tablets (400 MG). The contractor is responsible for providing the antibiotic tablets in 30-count bottles, ensuring all products are sourced or manufactured in accordance with Good Manufacturing Practices and FDA approval and registration requirements. Logistical compliance is critical, as the contract mandates adherence to RP001 DLA Packaging Requirements and the use of climate-controlled storage and transport to maintain product integrity. Performance will take place in FPO 09591, with the primary objective of supporting prime contractors on DLA supply contracts.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Activated Charcoal, SuspensionThis subcontract, issued by the Medical Supply Chain Pharm FSA under the Department of Defense, requires the provision of activated charcoal in suspension form, identified by NSN 6505012828880. The materials must be delivered to the USS Lewis B Puller ESB 3, with all shipments adhering to strict DLA packaging requirements and technical specifications. The contract falls under NAICS code 325412 and is intended for prime contractors supporting DLA supply operations. Resellers are specifically required to comply with the Non-Manufacturer Rule to ensure eligibility. The performance location is designated as FPO 09591, with a response deadline set for October 26, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of 4% Chlorhexidine Gluconate Surgical DetergentThis subcontract involves the supply of FDA-regulated 4% Chlorhexidine Gluconate surgical detergent for prime contractors supporting Department of Defense supply contracts. The provider is responsible for manufacturing or sourcing the chemical compound in strict accordance with NSN 6505-01-101-3759 specifications and DLA Packaging Requirements RP001. To maintain quality and regulatory compliance, the product must be produced in FDA-approved pharmaceutical manufacturing facilities. The contract mandates a total shelf life of 24 months, with a requirement that the detergent possesses at least 21 months of remaining shelf life at the time of delivery. Managed under the Medical Supply Chain Pharm FSA, the performance of this contract is centered in FPO 96660, falling under NAICS code 325412.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Bupivacaine and Epinephrine InjectionThis subcontract involves the supply of Bupivacaine and Epinephrine Injection to prime contractors supporting DLA Troop Support medical supply contracts. The provider must deliver end items compliant with NSN 6505-01-189-3973, utilizing pharmaceutical-grade materials and medical-grade packaging. To qualify, the supplier is required to hold all necessary pharmaceutical manufacturing licenses and maintain FDA approval for the specific drug formulation. Managed by the Department of Defense under the Medical Supply Chain Pharm FSA, the contract specifies the delivery of injectable medication quantities as outlined in the award. The performance location is designated as FPO 09591, and the procurement falls under NAICS code 325412.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Isoniazid Tablet ManufacturingThis subcontract involves the manufacturing of Isoniazid 300 MG tablets for prime contractors supporting Department of Defense pharmaceutical supply contracts through the Medical Supply Chain Pharm FSA. The manufacturer is responsible for producing tablets that conform to United States Pharmacopeia standards, packaged in bottles of 100 units. To execute this contract, the provider must utilize pharmaceutical grade API, specialized tablet pressing equipment, and a USP-compliant quality control laboratory. Strict regulatory adherence is required, including the maintenance of active FDA registration and continuous USP compliance. The performance of this contract is centered in FPO 09591, with the primary objective of delivering finished pharmaceutical products that meet all specified government quality and safety benchmarks.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Tetrahydrozoline Hydrochloride Ophthalmic Solution SupplierThis subcontract involves the supply of Tetrahydrozoline Hydrochloride Ophthalmic Solution, USP (0.05%, 15 ML) to support prime contractors under DLA Troop Support medical supply contracts. The selected provider is responsible for manufacturing or sourcing the pharmaceutical solution in accordance with USP standards, utilizing sterile ophthalmic bottling and packaging. All operations must comply with FDA approval and registration requirements for pharmaceutical manufacturing. The contract is managed by the Department of Defense under the Medical Supply Chain Pharm FSA. Physical deliveries of the ophthalmic solution are to be made to either the prime contractor or the Naval Med Readiness Logistics Command, with the place of performance located in Williamsburg, Virginia.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Tolnaftate Powder, USP 1%This subcontract through the Department of Defense Medical Supply Chain Pharm FSA involves the supply of Tolnaftate Powder, USP 1%, to prime contractors on DLA Troop Support medical supply contracts. The requirement is for 15 bottles of 45 GM powder, identified by NSN 6505014807897, which must strictly adhere to USP 1% standards and the DLA Master List of Technical and Quality Requirements. Eligible providers must possess the necessary pharmaceutical manufacturing and distribution licenses to fulfill the order. The performance of this contract is designated for FPO 09591, with a response deadline set for October 26, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

2 days ago

DEADLINE

in 5 days

AI Contract Overview

The contract titled "6505--770_Pharmaceuticals_VA CMOP National Office_36C77025Q0206" is an award notice issued by the Department of Veterans Affairs, specifically through its National CMOP Office (36C770). Posted on June 10, 2025, the contract, solicitation number 36C77025Q0206, is classified under NAICS code 325412, which pertains to pharmaceutical preparation manufacturing, and has a product/service code of 6505, relating to drugs and biologicals. The award totals $827,751.12 and was granted to Pharmacy Buying Association, Inc., based in Kansas City, Missouri (CAGE code 4NFE8, UEI: CN3LREBPMXJ9). The official award number is 36C77025P0180, with the same date as the posting. The contracting office is located in Leavenworth, Kansas, and the main point of contact for this agreement is Michael W. McAlhaney, a contract specialist who can be reached at Michael.McAlhaney@va.gov or (913) 684-1976. While the full details regarding the contract’s period of performance and precise place of performance are not specified, the contract is currently active and set to be archived by August 9, 2025. The award supports the procurement of pharmaceuticals for the Veterans Affairs’ Consolidated Mail Outpatient Pharmacy (CMOP) National Office and appears to be a significant investment in maintaining the pharmaceutical supply chain for VA facilities. Further documentation and details can be found through the provided links to the SAM.gov opportunity posting.

General Info

Veterans Affairs awarded $827,751 pharmaceutical supply contract to Pharmacy Buying Association, active until August 2025.

Agency

Department Of Veterans Affairs → National Cmop Office (36C770)

Contract Value

$827,751.12

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

KS, USA

Set-Aside

NONE

Awardee

PHARMACY BUYING ASSOCIATION, INC.

Award Issued Date

06/10/2025, 12:00:00 AM UTC

Documents

Award Notice 36C77025P0180 - Pharmacy Buying Association, Inc.

3 pages · award

Low

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseAwarded

PostedApr 15

Presolicitation

Type ChangedApr 15

Presolicitation → Solicitation

AwardedJun 10

Contract was awarded

Submission Closed

06/10/2025, 12:00:00 PM UTC

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Veterans Affairs → National Cmop Office (36C770)

Contacts1 person available

OfficeLEAVENWORTH, KS, 66048, USA

Organization / AgencyDepartment Of Veterans Affairs → National Cmop Office (36C770)

Office AddressLEAVENWORTH, KS, 66048, USA

Contacts

Michael W. McAlhaneyContract Specialist

contact@example.gov

+1 (555) 000-0000

Full Description

System updates may lag policy updates. The System for Award Management (SAM) may continue to require entities to complete representations based on provisions that are not included in agency solicitations. Examples include 52.222-25, Affirmative Action Compliance, and paragraph (d) of 52.212-3, Offeror Representations and Certifications Commercial Products and Commercial Services. Contracting officers will not consider these representations when making award decisions or enforce requirements. Entities are not required to, nor are they able to, update their entity registration to remove these representations in SAM. The Department of Veterans Affairs, National CMOP Contracting Office has a(n) STANDARD requirement to procure the miscellaneous Pharmaceuticals listed below for delivery to the CMOP facility in MULTIPLE LOCATIONS. 1 ITEM ID NO. 15242 IBUPROFEN 400MG TAB 500CT (I0004) PKG: 500 per BT, QTY: 1080 2 ITEM ID NO. 14801 IBUPROFEN 600MG TAB 500CT (I0005) PKG: 500 per BT, QTY: 324 3 ITEM ID NO. 14800 IBUPROFEN 800MG TAB 500CT (I0006) PKG: 500 per BT, QTY: 540 4 ITEM ID NO. 15242 IBUPROFEN 400MG TAB 500CT (I0004) PKG: 500 per BT, QTY: 2160 5 ITEM ID NO. 14801 IBUPROFEN 600MG TAB 500CT (I0005) PKG: 500 per BT, QTY: 2880 6 ITEM ID NO. 14800 IBUPROFEN 800MG TAB 500CT (I0006) PKG: 500 per BT, QTY: 864 7 ITEM ID NO. 15242 IBUPROFEN 400MG TAB 500CT (I0004) PKG: 500 per BT, QTY: 2160 8 ITEM ID NO. 14801 IBUPROFEN 600MG TAB 500CT (I0005) PKG: 500 per BT, QTY: 1800 9 ITEM ID NO. 14800 IBUPROFEN 800MG TAB 500CT (I0006) PKG: 500 per BT, QTY: 3600 10 ITEM ID NO. 15242 IBUPROFEN 400MG TAB 500CT (I0004) PKG: 500 per BT, QTY: 1080 11 ITEM ID NO. 14801 IBUPROFEN 600MG TAB 500CT (I0005) PKG: 500 per BT, QTY: 720 12 ITEM ID NO. 14800 IBUPROFEN 800MG TAB 500CT (I0006) PKG: 500 per BT, QTY: 1440 13 ITEM ID NO. 15242 IBUPROFEN 400MG TAB 500CT (I0004) PKG: 500 per BT, QTY: 720 14 ITEM ID NO. 14801 IBUPROFEN 600MG TAB 500CT (I0005) PKG: 500 per BT, QTY: 1080 15 ITEM ID NO. 14800 IBUPROFEN 800MG TAB 500CT (I0006) PKG: 500 per BT, QTY: 1296 16 ITEM ID NO. 15242 IBUPROFEN 400MG TAB 500CT (I0004) PKG: 500 per BT, QTY: 4440 17 ITEM ID NO. 14801 IBUPROFEN 600MG TAB 500CT (I0005) PKG: 500 per BT, QTY: 7200 18 ITEM ID NO. 14800 IBUPROFEN 800MG TAB 500CT (I0006) PKG: 500 per BT, QTY: 6600 19 ITEM ID NO. 15242 IBUPROFEN 400MG TAB 500CT (I0004) PKG: 500 per BT, QTY: 2304 20 ITEM ID NO. 14801 IBUPROFEN 600MG TAB 500CT (I0005) PKG: 500 per BT, QTY: 4392 21 ITEM ID NO. 14800 IBUPROFEN 800MG TAB 500CT (I0006) PKG: 500 per BT, QTY: 11088 22 ITEM ID NO. 14801 IBUPROFEN 600MG TAB 500CT (I0005) PKG: 500 per BT, QTY: 1620 23 ITEM ID NO. 14800 IBUPROFEN 800MG TAB 500CT (I0006) PKG: 500 per BT, QTY: 4500 24 ITEM ID NO. 14801 IBUPROFEN 600MG TAB 500CT (I0005) PKG: 500 per BT, QTY: 2160 25 ITEM ID NO. 14800 IBUPROFEN 800MG TAB 500CT (I0006) PKG: 500 per BT, QTY: 3888 26 ITEM ID NO. 15242 IBUPROFEN 400MG TAB 500CT (I0004) PKG: 500 per BT, QTY: 432 27 ITEM ID NO. 14801 IBUPROFEN 600MG TAB 500CT (I0005) PKG: 500 per BT, QTY: 720 28 ITEM ID NO. 14800 IBUPROFEN 800MG TAB 500CT (I0006) PKG: 500 per BT, QTY: 1344 29 ITEM ID NO. 14801 IBUPROFEN 600MG TAB 500CT (I0005) PKG: 500 per BT, QTY: 864 30 ITEM ID NO. 14800 IBUPROFEN 800MG TAB 500CT (I0006) PKG: 500 per BT, QTY: 2592 31 ITEM ID NO. 15242 IBUPROFEN 400MG TAB 500CT (I0004) PKG: 500 per BT, QTY: 1440 32 ITEM ID NO. 14801 IBUPROFEN 600MG TAB 500CT (I0005) PKG: 500 per BT, QTY: 1800 33 ITEM ID NO. 14800 IBUPROFEN 800MG TAB 500CT (I0006) PKG: 500 per BT, QTY: 2880 One or more of the items under this acquisition is subject to the World Trade Organization Government Procurement Agreement and Free Trade Agreements. Preference for U.S.-made or designated country end products. (See FAR 52.225-5, 52.225-6) Subject: 770_Pharmaceuticals_VA CMOP National Office_36C77025Q0206 Solicitation Number: 36C77025Q0206 Set-aside Status: UNRESTRICTED Estimated Issue Date: 04-17-25 Closing Response Date: 04-24-25 @09:00 AM (CST) Estimated Award Date: 04-29-25 Classification Code: 65, Medical Equipment Product or Service Code: 6505, Drugs and Biologicals NAICS Code: 325412, Pharmaceutical Preparation Manufacturing DELIVERY TIMEFRAME: 10 Days ARO FOB: Destination Vendor pays shipping quote accordingly Delivered/Distributed among 8 CMOP Location(s) See RFQ Quote Spreadsheet for Delivery Location(s). All responsible sources may submit a quotation which shall be considered by this agency. Responses must be concise and be specifically directed to the requirement referenced above. Price Schedule must be returned in excel format in the solicitation attachments. Company and Point of Contact information must be filled out. Manufacturer name must be filled out. Product Country of Origin must be filled out. Vendors that fail to provide the Price Schedule and required information may be deemed technically unacceptable. Offeror shall supply their state wholesale distributor licensure with offer verifying compliance with the Drug Supply Chain Security Act (DSCSA) with their quote. Vendors that fail to submit a copy of their state license may be deemed technically unacceptable. The solicitation for this acquisition will be posted on Contract Opportunities (sam.gov). It is the vendors responsibility to monitor Contract Opportunities (sam.gov) for changes or amendments. All solicitation packages will be submitted via email. Submit quotes with confirmed quantities ready for shipment. Solicitation Package shall include: 1. SF1449 - Solicitation cover page (Signed) 2. Quote - Price Schedule (Excel format) 3. State Wholesale Distributor License 4. 52.225-6 TRADE AGREEMENTS CERTIFICATE.docx (Completed) Submit the RFQ to Michael.McAlhaney@va.gov, phone number (913) 684-0134.